Series A Memo



Written by:
Yiwen
Reading Time:
3
min
Patients with life-threatening conditions need treatment immediately. In a world of increasingly abundant treatment options, the bottleneck isn't the therapy itself, it's the ability to communicate to patients and providers why a specific therapy is the right choice for them. Pharmaceutical companies need a way to reach patients and physicians efficiently, with the right message at the right time. The current content production process makes this nearly impossible: if a single email takes 3 months to produce, how can a brand create personalized messaging for different audiences, let alone test and iterate to understand what resonates?
We built Solstice to change that.
We help brand teams reach healthcare professionals and patients quickly, without sacrificing compliance.
Speed is the differentiator.
The faster a brand can deploy one new asset, the faster they can learn what resonates.
In an industry where minutes make all the difference, speed becomes more than just a differentiator. It's what’s necessary to make sure patients get the treatment they need.
Aris & Yiwen
Read other articles

FEATURED |
Feb 2, 2024
Introducing the Solstice Fair Balance Score
A novel approach of quantifying risk and benefit information in promotional documents

FEATURED |
Feb 2, 2024
Introducing the AI Regulatory Assistant for Life Sciences Marketing
Overview of Solstice's AI-enabled regulatory platform for marketing teams

FEATURED |
Feb 2, 2024
Product-focused messaging stifles variability in content
Pharmaceutical marketing has traditionally been product-focused.
